BioConvergence Celebrates Third Anniversary
BLOOMINGTON, INDIANA-April 17, 2009-BioConvergence, a Bloomington, Indianabased contract solutions provider to the biotech and pharmaceutical industries, celebrates its 3rd year of operations in the life sciences industry. Recent accomplishments include:
-Retaining 99% of its more than 100 clients, including 10% from the State of Indiana and 10% from outside the United States
-Attracting more than 40 life sciences professionals and expanding facilities to serve more clients
-Adding new clinical manufacturing, packaging and QC testing services to complement its existing core of product development and supply chain
management services
-Consistently increasing revenue by providing the functions that enable clients to reach the clinic faster at reduced costs
-Leveraging the strengths of clients, employees and board members to become a collaborative partner for companies adopting the Fully Integrated Pharmaceutical Network, or FIPnet, drug development model
“We are blessed to be celebrating this special day,” said Alisa Wright, CEO and founder of BioConvergence. “At a time when challenging economic conditions have changed the game for virtually all businesses and industries, we are grateful our clients continue to trust us to develop their life-saving products.”
About BioConvergence LLC
BioConvergence is a leading contract solutions provider for the biotech and pharmaceutical industries. We offer the following services for our global client base: product development, cGMP supply chain & materials management, toxicology and clinical materials manufacturing & packaging, QC testing and consulting services. BioConvergence is the first solutions provider to offer its secure E-Transparency Solution enabling clients to access their data 24/7. BioConvergence is a women-owned, small business based in Bloomington, Indiana. For more information, visit us at www.bioc.us.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
